Equities

Shandong Pharmaceutical Glass Co Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Shandong Pharmaceutical Glass Co Ltd

Actions
Health CareMedical Equipment and Services
  • Price (CNY)20.15
  • Today's Change-0.21 / -1.03%
  • Shares traded5.91m
  • 1 Year change-17.38%
  • Beta0.9655
Data delayed at least 15 minutes, as of Feb 13 2026.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

SHANDONG PHARMACEUTICAL GLASS CO., LTD is a China-based company principally engaged in the research and development, manufacture and distribution of pharmaceutical glass products. The Company's products include molded pharmaceutical glass bottles, ampoules, phials, brown bottles, butyl rubber plugs, aluminum tops and others. The Company distributes its products in domestic and overseas markets.

  • Revenue in CNY (TTM)4.70bn
  • Net income in CNY765.01m
  • Incorporated1993
  • Employees7.12k
  • Location
    Shandong Pharmaceutical Glass Co LtdYiyuan CountyZIBO 256100ChinaCHN
  • Phone+86 5 333259028
  • Fax+86 5 333249700
  • Websitehttp://www.pharmglass.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Shanghai Sunglow Packaging Techng Co Ltd1.04bn127.84m7.01bn896.0054.898.01--6.730.42180.42183.432.890.70076.773.881,161,452.009.512.0714.622.8826.8018.0913.573.410.799519.020.257675.4027.5522.18755.2534.733.1328.47
Shanghai Baosteel Packaging Co Ltd8.74bn191.17m7.58bn1.33k38.711.66--0.86720.15350.15356.993.580.93998.014.616,565,682.002.293.074.686.196.998.742.433.240.671512.030.109850.877.197.59-21.136.2224.43-0.7917
Wuzhou Special Paper Group Co Ltd8.65bn215.81m7.82bn3.23k35.112.18--0.9040.4680.46818.927.530.79478.178.482,678,656.002.005.373.649.946.7411.862.525.930.38412.110.647732.6817.4326.3733.2012.6747.81--
Shanghai Zijiang Enterprise Group Co Ltd11.27bn1.25bn11.45bn6.79k9.191.72--1.020.82180.82187.434.400.80794.306.311,659,740.009.255.4616.279.4621.7021.0811.457.040.9844--0.349363.8116.692.9244.5510.3526.978.45
Shandong Pharmaceutical Glass Co Ltd4.70bn765.01m13.37bn7.12k17.481.64--2.841.151.157.0812.280.47342.294.91660,601.007.709.249.4611.7631.3029.0716.2716.172.60--0.0034.712.8711.3621.5515.501.8315.63
Data as of Feb 13 2026. Currency figures normalised to Shandong Pharmaceutical Glass Co Ltd's reporting currency: Chinese Yuan Renminbi CNY

Institutional shareholders

8.91%Per cent of shares held by top holders
HolderShares% Held
Hwabao WP Fund Management Co., Ltd.as of 30 Jun 202522.12m3.33%
China Southern Asset Management Co., Ltd.as of 30 Jun 202510.51m1.58%
Hongde Fund Management Co., Ltd.as of 30 Jun 20258.98m1.35%
GF Fund Management Co., Ltd.as of 30 Jun 20255.22m0.79%
Guotai Asset Management Co., Ltd.as of 30 Jun 20252.70m0.41%
China Asset Management Co., Ltd.as of 30 Jun 20252.22m0.33%
Harvest Fund Management Co., Ltd.as of 30 Jun 20252.17m0.33%
The Vanguard Group, Inc.as of 31 Dec 20251.90m0.29%
Maxwealth Fund Management Co., Ltd.as of 30 Jun 20251.80m0.27%
E Fund Management Co., Ltd.as of 30 Jun 20251.47m0.22%
More ▼
Data from 30 Jun 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.